Wolverine Trading, LLC Cytosorbents Corp Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	BUY	$3.77 - $7.73 $97,020 - $198,931	25,735 New	25,735 $169,000
Q4 2019 Feb 12, 2020	SELL	$3.61 - $5.22 $58,539 - $84,647	-16,216 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.33 - $7.63 $26,378 - $46,481	6,092 Added 60.17%	16,216 $82,000
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $49,681 - $89,074	-7,047 Reduced 41.04%	10,124 $79,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $82,869 - $112,006	-7,568 Reduced 30.59%	17,171 $222,000
Q1 2018 May 15, 2018	SELL	$6.55 - $8.2 $61,714 - $77,260	-9,422 Reduced 27.58%	24,739 $174,000
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $85,048 - $101,625	14,415 Added 73.0%	34,161 $222,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $6.2 $88,857 - $122,425	19,746	19,746 $122,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.